The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey
Küçük Resim Yok
Tarih
2018
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Oxford University Press
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[Abstract Not Available]
Açıklama
43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY
WOS: 000459277303171
WOS: 000459277303171
Anahtar Kelimeler
Kaynak
43rd ESMO Congress (ESMO)
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
29
Sayı
Supplement: 8
Künye
Kılıçkap, S., Ölmez, Ö. F., Cicin, İ., Demirci, U., Alan, O., Çabuk, D. ... Sakin, A. (2018). The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey. 43rd ESMO Congress (ESMO) içinde (505-505. ss.). Munich, Germany, October 19-23, 2018.
